[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "A PhD student used BD Rhapsody system to achieve single cell barcoding in a high throughput manner. Single cell barcoding was achieved using magnetic beads that were linked with a DNA oligo containing a universal oligo, cell label, UMI and a PolydT tail. This schematic worked well to generate sequencing libraries for Abseq, Sample Tag, and targeted mRNA panels. Subsequent next generation sequencing using 75 by 225 configuration on Illumina sequencer also worked well. Recently, the PhD student wanted to add single cell TCR transcript capture and sequencing. He tried to use the same bead schematic and sequencing modality for TCR transcript capturing and sequencing, but he was not able to obtain the CDR3 region sequences on the TCR. He would like to keep the sequencing modality as 75 by 225 since this was the cheapest option. Moreover, he would like to keep using the BD Rhapsody system to achieve single cell capturing and labeling in a high throughout manner. What could he do to appropriately obtain the CDR3 region sequences?\n\n\nAnswer Choices:\nA. First Step: Use the existing poly(dT) tail to capture the mRNA as usual. Second Step: Add TCR-specific capture oligos to the beads. These oligos should hybridize to sequences upstream of the V(D)J junctions, which include the CDR3 region. This will ensure specific capture of the TCR transcripts.\nB. Add template switch oligos (TSO) after UMI on the DNA oligo on the beads. After reverse transcription, add TSO to 3\u2019 end during PCR reaction to achieve template switching.\nC. Modify the beads to include capture oligos specific to the TCR regions, particularly focusing on the conserved regions flanking the CDR3. These capture oligos should be designed to bind upstream and downstream of the CDR3 region to ensure it is included in the captured sequence.\nD. After capturing the TCR transcripts, design primers that bind to the regions flanking the CDR3 region for subsequent PCR amplification.\nE. Use a different sequencing modality such as 2 by 150."
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762216769-61u4CBkyIRejafV6nzHx",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"To appropriately obtain the CDR3 region sequences for TCR, the PhD student needs to adapt the bead-based capture mechanism. The existing poly(dT) tail on the beads primarily captures the 3' end of mRNA molecules. While TCR transcripts have poly(A) tails, the CDR3 region is located much further upstream from the 3' end, in the V(D)J region. A standard 3' tag sequencing approach (even with a 225 bp reverse read) might not consistently cover the entire CDR3 region, or might not efficiently capture enough of the full-length V(D)J region.  \\n\\nTherefore, the most effective solution is to modify the capture chemistry on the beads to specifically target TCR transcripts in a way that ensures the V(D)J and CDR3 regions are captured and sequenced. This involves using capture oligos designed to bind to conserved regions of the TCR transcripts, typically within the constant region or specific framework regions, which are located 'downstream' of the CDR3 (in the 3' direction of the mRNA). When reverse transcription is initiated from these specific oligos, the resulting cDNA will span the CDR3 region and extend towards the 5' end of the mRNA, allowing for its complete sequencing. This is a common strategy employed by targeted TCR sequencing kits.\",\n  \"answer_letter\": \"C\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Evaluating the Problem Space**\n\nI'm focused on the user's need: optimizing TCR CDR3 capture and sequencing with the BD Rhapsody. Initial thoughts revolve around leveraging the existing bead-based single-cell capture method and the 75x225 sequencing. My focus is on determining the optimal approach within these constraints, aiming to maximize data yield and efficiency. The core challenge is the best way to utilize the system for this purpose.\n\n\n**Assessing the Constraints**\n\nI'm now zeroing in on the challenge of capturing the CDR3 region. The poly(dT) capture method presents a hurdle, since the TCR CDR3 lies upstream of the poly(A) tail. My current thinking leans towards strategies to get better coverage. I'm exploring options that might extend sequence reads to capture the CDR3, considering the limitations of the 75x225 sequencing. This means considering how far the read extends from the poly(A) tail.\n\n\n**Defining the Approach**\n\nI'm now considering how to tailor the strategy for CDR3 capture. The initial idea of adding TCR-specific oligos to the beads seems promising for focused enrichment. I'm carefully analyzing its implications on the Rhapsody system. I'm focusing on the potential modification of the existing capture method, weighing the benefits against potential complexities. The core questions are: how to integrate TCR-specific capture while maintaining the current workflow and maximizing CDR3 coverage within the 75x225 read constraints.\n\n\n**Considering Strategy Refinements**\n\nI'm now grappling with the addition of TCR-specific capture oligos. The idea is sound, but the implications within the Rhapsody workflow are complex. The challenge is in ensuring efficient CDR3 capture while maintaining the current single-cell approach. I'm focusing on the integration of these oligos. The aim is specific targeting within the constraints of the 75x225 reads.\n\n\n**Assessing Solution Strategies**\n\nI'm now closely scrutinizing the proposed solutions. Adding TCR-specific capture oligos seems promising, although the integration details require more thought. Furthermore, I'm finding inconsistencies in the second approach involving template switch oligos. The wording on how and where the TSO is added, relative to the bead oligo, seems incorrect and I am continuing to evaluate its overall feasibility within the existing framework. I'm focusing on the technical soundness of each proposed method and whether they align with the Rhapsody workflow.\n\n\n**Assessing the Approaches**\n\nI'm now weighing the answer choices, focusing on technical feasibility within the BD Rhapsody system. Option A seems like a viable modification, although the wording is confusing. Option B doesn't seem to be correct about the process and timing of the TSO. Option C seems promising as it targets the critical CDR3 regions effectively. The main goal is to select the most practical approach.\n\n\n**Considering Solution Refinement**\n\nI'm now revisiting answer choices in light of the constraints and objectives. The wording in Option A is confusing; it contradicts itself by suggesting both poly(dT) and TCR-specific capture. Option B seems technically incorrect about TSO application, further diminishing its appeal. Option C appears the most technically sound. The focus is to identify the best way of targeting the TCR transcripts for the required coverage.\n\n\n**Refining Solution Selection**\n\nI'm now prioritizing the most effective solution, scrutinizing the answer choices. Option A's description, while appearing viable at first glance, presents wording issues that decrease my confidence. Option C is a clear winner because it focuses on a targeted capture that directly addresses the problem. This solution directly addresses the technical issue by making a targeted capture approach.\n\n\n**Refining the Solution**\n\nI'm now prioritizing the best answer, evaluating the details in each option. Option A presents some conflicting wording, especially regarding the initial capture method. The core problem is effective CDR3 capture. The approach described in Option C is targeted towards that. The main focus is to ensure the specific targeting of the necessary TCR transcript regions.\n\n\n**Finalizing the Selection**\n\nI'm now fully committed to the best solution, and the choice is clear. Option A had conflicting wording, while Option B has some technical issues in the description. Option C provides the targeted approach required to address the challenge, and I am confident in its potential. The core focus is targeted enrichment for TCR transcripts.\n\n\n**Evaluating the Best Option**\n\nI'm now prioritizing the most effective solution, scrutinizing the answer choices. Option A, although at first glance, seems ambiguous. Option C is a clear winner because it's targeted, as I initially thought. It targets the CDR3 regions effectively. The main goal is to capture the TCR transcripts.\n\n\n**Prioritizing the Best Option**\n\nI'm now fully focused on selecting the best answer, evaluating the details in each answer. Option C continues to stand out because of its direct and effective approach. Its targeted capture method addresses the problem. I'm focusing on the best way to get the CDR3.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Evaluating the Problem Space**\n\nI'm focused on the user's need: optimizing TCR CDR3 capture and sequencing with the BD Rhapsody. Initial thoughts revolve around leveraging the existing bead-based single-cell capture method and the 75x225 sequencing. My focus is on determining the optimal approach within these constraints, aiming to maximize data yield and efficiency. The core challenge is the best way to utilize the system for this purpose.\n\n\n**Assessing the Constraints**\n\nI'm now zeroing in on the challenge of capturing the CDR3 region. The poly(dT) capture method presents a hurdle, since the TCR CDR3 lies upstream of the poly(A) tail. My current thinking leans towards strategies to get better coverage. I'm exploring options that might extend sequence reads to capture the CDR3, considering the limitations of the 75x225 sequencing. This means considering how far the read extends from the poly(A) tail.\n\n\n**Defining the Approach**\n\nI'm now considering how to tailor the strategy for CDR3 capture. The initial idea of adding TCR-specific oligos to the beads seems promising for focused enrichment. I'm carefully analyzing its implications on the Rhapsody system. I'm focusing on the potential modification of the existing capture method, weighing the benefits against potential complexities. The core questions are: how to integrate TCR-specific capture while maintaining the current workflow and maximizing CDR3 coverage within the 75x225 read constraints.\n\n\n**Considering Strategy Refinements**\n\nI'm now grappling with the addition of TCR-specific capture oligos. The idea is sound, but the implications within the Rhapsody workflow are complex. The challenge is in ensuring efficient CDR3 capture while maintaining the current single-cell approach. I'm focusing on the integration of these oligos. The aim is specific targeting within the constraints of the 75x225 reads.\n\n\n**Assessing Solution Strategies**\n\nI'm now closely scrutinizing the proposed solutions. Adding TCR-specific capture oligos seems promising, although the integration details require more thought. Furthermore, I'm finding inconsistencies in the second approach involving template switch oligos. The wording on how and where the TSO is added, relative to the bead oligo, seems incorrect and I am continuing to evaluate its overall feasibility within the existing framework. I'm focusing on the technical soundness of each proposed method and whether they align with the Rhapsody workflow.\n\n\n**Assessing the Approaches**\n\nI'm now weighing the answer choices, focusing on technical feasibility within the BD Rhapsody system. Option A seems like a viable modification, although the wording is confusing. Option B doesn't seem to be correct about the process and timing of the TSO. Option C seems promising as it targets the critical CDR3 regions effectively. The main goal is to select the most practical approach.\n\n\n**Considering Solution Refinement**\n\nI'm now revisiting answer choices in light of the constraints and objectives. The wording in Option A is confusing; it contradicts itself by suggesting both poly(dT) and TCR-specific capture. Option B seems technically incorrect about TSO application, further diminishing its appeal. Option C appears the most technically sound. The focus is to identify the best way of targeting the TCR transcripts for the required coverage.\n\n\n**Refining Solution Selection**\n\nI'm now prioritizing the most effective solution, scrutinizing the answer choices. Option A's description, while appearing viable at first glance, presents wording issues that decrease my confidence. Option C is a clear winner because it focuses on a targeted capture that directly addresses the problem. This solution directly addresses the technical issue by making a targeted capture approach.\n\n\n**Refining the Solution**\n\nI'm now prioritizing the best answer, evaluating the details in each option. Option A presents some conflicting wording, especially regarding the initial capture method. The core problem is effective CDR3 capture. The approach described in Option C is targeted towards that. The main focus is to ensure the specific targeting of the necessary TCR transcript regions.\n\n\n**Finalizing the Selection**\n\nI'm now fully committed to the best solution, and the choice is clear. Option A had conflicting wording, while Option B has some technical issues in the description. Option C provides the targeted approach required to address the challenge, and I am confident in its potential. The core focus is targeted enrichment for TCR transcripts.\n\n\n**Evaluating the Best Option**\n\nI'm now prioritizing the most effective solution, scrutinizing the answer choices. Option A, although at first glance, seems ambiguous. Option C is a clear winner because it's targeted, as I initially thought. It targets the CDR3 regions effectively. The main goal is to capture the TCR transcripts.\n\n\n**Prioritizing the Best Option**\n\nI'm now fully focused on selecting the best answer, evaluating the details in each answer. Option C continues to stand out because of its direct and effective approach. Its targeted capture method addresses the problem. I'm focusing on the best way to get the CDR3.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762216769,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 3173,
        "prompt_tokens": 422,
        "total_tokens": 3595,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 2882,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.007978509,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001266,
          "upstream_inference_completions_cost": 0.0079325
        }
      },
      "provider": "Google"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "A PhD student used BD Rhapsody system to achieve single cell barcoding in a high throughput manner. Single cell barcoding was achieved using magnetic beads that were linked with a DNA oligo containing a universal oligo, cell label, UMI and a PolydT tail. This schematic worked well to generate sequencing libraries for Abseq, Sample Tag, and targeted mRNA panels. Subsequent next generation sequencing using 75 by 225 configuration on Illumina sequencer also worked well. Recently, the PhD student wanted to add single cell TCR transcript capture and sequencing. He tried to use the same bead schematic and sequencing modality for TCR transcript capturing and sequencing, but he was not able to obtain the CDR3 region sequences on the TCR. He would like to keep the sequencing modality as 75 by 225 since this was the cheapest option. Moreover, he would like to keep using the BD Rhapsody system to achieve single cell capturing and labeling in a high throughout manner. What could he do to appropriately obtain the CDR3 region sequences?\n\n\nAnswer Choices:\nA. First Step: Use the existing poly(dT) tail to capture the mRNA as usual. Second Step: Add TCR-specific capture oligos to the beads. These oligos should hybridize to sequences upstream of the V(D)J junctions, which include the CDR3 region. This will ensure specific capture of the TCR transcripts.\nB. Add template switch oligos (TSO) after UMI on the DNA oligo on the beads. After reverse transcription, add TSO to 3\u2019 end during PCR reaction to achieve template switching.\nC. Modify the beads to include capture oligos specific to the TCR regions, particularly focusing on the conserved regions flanking the CDR3. These capture oligos should be designed to bind upstream and downstream of the CDR3 region to ensure it is included in the captured sequence.\nD. After capturing the TCR transcripts, design primers that bind to the regions flanking the CDR3 region for subsequent PCR amplification.\nE. Use a different sequencing modality such as 2 by 150."
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762216769-7F5GvEg8yLaHkd6jtOCF",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Modify the beads to include capture oligos specific to the TCR regions, particularly focusing on the conserved regions flanking the CDR3. These capture oligos should be designed to bind upstream and downstream of the CDR3 region to ensure it is included in the captured sequence.\",\n  \"answer_letter\": \"C\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Addressing TCR Capture Failure**\n\nI'm currently focused on the failure to capture TCR CDR3 regions using our BD Rhapsody system. The current poly(dT) mRNA capture strategy works for other assays, but not for the TCR sequences. I'm considering the possibility that the issue lies in the length or structure of the TCR transcripts relative to the other targets. Perhaps the reverse transcription is not working for these sequences.\n\n\n**Examining Read Coverage Issues**\n\nGiven the Illumina 75x225 setup, I'm now focusing on how read coverage affects the CDR3 region. Since the poly(dT) primer is at the 3' end, the 225 bp Read 2 might not reach the CDR3. The problem statement says I'm using the same bead schematic and sequencing modality as other successful assays, and the location of the CDR3 within the transcript relative to the poly(A) tail is the most likely culprit.\n\n\n**Refining Capture Strategies**\n\nI'm now thinking about modifying the capture strategy, as the poly(dT) might not be enough. The core idea of using TCR-specific oligos on the beads is good, because it directly targets the CDR3 region. However, I need to check if changing the bead schematic is permissible. Furthermore, the positioning of the oligos, specifically upstream of the V(D)J junctions, is crucial for CDR3 coverage, and I will be looking to test this in silico.\n\n\n**Revisiting Read Placement**\n\nI'm now contemplating how the read lengths interact with the TCR transcripts. The key is positioning Read 2 to encompass the CDR3. Given the poly(dT) priming, I'm concerned the 225 bp read might not be sufficient. I'm exploring an option to add TCR-specific oligos to the beads, upstream of the V(D)J junctions, ensuring targeted CDR3 capture within the read length.\n\n\n**Reassessing Bead Modifications**\n\nI'm now back to the question of bead modification. Adding oligos targeting conserved TCR regions around the CDR3 seems like the most direct solution. I'm carefully considering how to integrate these oligos into the existing Rhapsody workflow, whilst acknowledging that a change to the bead schematic might be required, but it's the most effective approach.\n\n\n**Prioritizing Oligo Design**\n\nI'm now focusing on optimizing the design of TCR-specific capture oligos. My current thought is to incorporate oligos targeting the conserved flanking regions of the CDR3 on the beads. Specifically, I'm thinking about how the oligos should be positioned to best ensure the CDR3 region is within the sequencing read, while acknowledging the 3' to 5' capture direction of the reverse transcription.\n\n\n**Evaluating Capture Strategies**\n\nI am now carefully weighing the capture options, and the main thrust of my current thinking revolves around designing TCR-specific capture oligos. While the core concept of modification to the beads holds promise, the exact positioning of these oligos is paramount. I'm focusing on ensuring they target the regions flanking the CDR3 to guarantee it falls within the 225 bp Read 2 sequencing window.\n\n\n**Considering Constant Region Probes**\n\nI'm now re-evaluating the role of bead modifications in TCR capture. Thinking about how the constant regions can act as anchor points for the oligo binding, allowing for better coverage. The key is in using probes that are complementary to the constant regions to increase the probability of capturing the CDR3 region within the Read 2 window.\n\n\n**Prioritizing Oligo Design**\n\nI'm now prioritizing the design of the TCR-specific capture oligos, and how those modifications would be applied to the beads. My primary focus is on how to best position these oligos relative to the CDR3 region. I want to ensure that the CDR3 is within the read length, while also considering how the reverse transcription would work on the beads.\n\n\n**Reflecting on TCR Sequencing**\n\nI'm now contemplating that modifying the existing bead design is the most probable path forward. The idea of using TCR-specific capture oligos on the beads, specifically targeting flanking sequences near the CDR3 region, seems like the most effective solution for ensuring targeted CDR3 capture during sequencing.\n\n\n**Considering CDR3 Coverage**\n\nI'm now contemplating how to improve the strategy for capturing and sequencing the TCR CDR3 region using the existing system and constraints. My current thinking is that to overcome the short read length, I need to design TCR-specific capture oligos that bind downstream of the CDR3, which should pull the region closer to the capture point.\n\n\n**Analyzing Capture Options**\n\nI am now focusing on the best way to get the CDR3 region into the read. Considering a 3' capture, I'm thinking specific capture oligos, potentially targeting the constant regions, are key. I'll need to see if the oligo design and read length will accommodate the CDR3.\n\n\n**Evaluating Targeted Priming**\n\nI'm now contemplating that modifying the beads is the preferred approach, especially in light of Rhapsody's TCR/BCR kits. Adding capture oligos targeting constant regions downstream of the CDR3, for reverse transcription, could bring the CDR3 within the read length during the initial capture and library preparation.\n\n\n**Considering Priming Locations**\n\nI'm now contemplating that modifying the beads is the most effective approach. The key lies in strategic capture, with particular emphasis on where the oligos should bind. The aim is to ensure that reverse transcription primes near the CDR3, bringing the region into the read. The potential modification would bring the constant regions closer.\n\n\n**Considering the Problem Statement**\n\nI'm now contemplating that modifying the beads is the most effective approach. The key lies in strategic positioning of capture oligos, perhaps designed to target regions downstream of the CDR3, to ensure the CDR3 lies within the sequencing read, and how this will be incorporated into the Rhapsody workflow.\n\n\n**Considering Rhapsody Bead Design**\n\nI'm now contemplating that modifying the beads is the preferred approach. The most effective strategy involves adding capture oligos to the bead. These should be designed to target the constant regions, downstream from the CDR3. This helps place the CDR3 region into the read.\n\n\n**Reflecting on TCR Capture**\n\nI'm now thinking about how to adapt the Rhapsody workflow to better capture the TCR CDR3 region. The key lies in modifying the beads. I'm considering adding TCR-specific oligos or replacing the poly(dT) tail, potentially targeting regions downstream of the CDR3, to ensure the region is sequenced.\n\n\n**Evaluating Oligo Incorporation**\n\nI'm now contemplating that modifying the beads to incorporate TCR-specific capture oligos is key. Considering how to best position these on the beads relative to the CDR3 region. The goal is the inclusion of the CDR3 within the read length during the reverse transcription process.\n\n\n**Considering Solution Approaches**\n\nI'm now contemplating that modifying the beads is the most effective way to address the issue. Adding TCR-specific capture oligos, perhaps targeting the constant regions, would facilitate the positioning of the CDR3 region for subsequent sequencing, though this presents a challenge to the existing workflow.\n\n\n**Considering Bead Modification Choices**\n\nI'm now contemplating that modifying the beads to improve TCR capture is the best option. I'm focusing on incorporating oligos that can target regions downstream from the CDR3. This approach aims to bring the CDR3 within the sequencing read length.\n\n**Considering Library Prep Strategies**\n\nI'm now contemplating that modifying the beads to improve the TCR capture will be necessary. My focus is on adding a strategy using oligos that target regions downstream from the CDR3, and how that will fit into the existing workflow.\n\n\n**Considering PCR Amplification After Capture**\n\nI'm now thinking about leveraging PCR amplification post-capture. The core of my current line of thinking revolves around designing primers to amplify the CDR3 region specifically after the initial capture phase. This may be a strong method of ensuring the inclusion of the CDR3 during sequencing.\n\n\n**Reflecting on TCR Sequencing**\n\nI'm now contemplating that modifying the existing bead design is the most probable path forward. The idea of using TCR-specific capture oligos on the beads, specifically targeting flanking sequences near the CDR3 region, seems like the most effective solution for ensuring targeted CDR3 capture during sequencing.\n\n\n**Reflecting on TCR Sequencing**\n\nI'm now contemplating that modifying the existing bead design is the most probable path forward. The idea of using TCR-specific capture oligos on the beads, specifically targeting flanking sequences near the CDR3 region, seems like the most effective solution for ensuring targeted CDR3 capture during sequencing.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Addressing TCR Capture Failure**\n\nI'm currently focused on the failure to capture TCR CDR3 regions using our BD Rhapsody system. The current poly(dT) mRNA capture strategy works for other assays, but not for the TCR sequences. I'm considering the possibility that the issue lies in the length or structure of the TCR transcripts relative to the other targets. Perhaps the reverse transcription is not working for these sequences.\n\n\n**Examining Read Coverage Issues**\n\nGiven the Illumina 75x225 setup, I'm now focusing on how read coverage affects the CDR3 region. Since the poly(dT) primer is at the 3' end, the 225 bp Read 2 might not reach the CDR3. The problem statement says I'm using the same bead schematic and sequencing modality as other successful assays, and the location of the CDR3 within the transcript relative to the poly(A) tail is the most likely culprit.\n\n\n**Refining Capture Strategies**\n\nI'm now thinking about modifying the capture strategy, as the poly(dT) might not be enough. The core idea of using TCR-specific oligos on the beads is good, because it directly targets the CDR3 region. However, I need to check if changing the bead schematic is permissible. Furthermore, the positioning of the oligos, specifically upstream of the V(D)J junctions, is crucial for CDR3 coverage, and I will be looking to test this in silico.\n\n\n**Revisiting Read Placement**\n\nI'm now contemplating how the read lengths interact with the TCR transcripts. The key is positioning Read 2 to encompass the CDR3. Given the poly(dT) priming, I'm concerned the 225 bp read might not be sufficient. I'm exploring an option to add TCR-specific oligos to the beads, upstream of the V(D)J junctions, ensuring targeted CDR3 capture within the read length.\n\n\n**Reassessing Bead Modifications**\n\nI'm now back to the question of bead modification. Adding oligos targeting conserved TCR regions around the CDR3 seems like the most direct solution. I'm carefully considering how to integrate these oligos into the existing Rhapsody workflow, whilst acknowledging that a change to the bead schematic might be required, but it's the most effective approach.\n\n\n**Prioritizing Oligo Design**\n\nI'm now focusing on optimizing the design of TCR-specific capture oligos. My current thought is to incorporate oligos targeting the conserved flanking regions of the CDR3 on the beads. Specifically, I'm thinking about how the oligos should be positioned to best ensure the CDR3 region is within the sequencing read, while acknowledging the 3' to 5' capture direction of the reverse transcription.\n\n\n**Evaluating Capture Strategies**\n\nI am now carefully weighing the capture options, and the main thrust of my current thinking revolves around designing TCR-specific capture oligos. While the core concept of modification to the beads holds promise, the exact positioning of these oligos is paramount. I'm focusing on ensuring they target the regions flanking the CDR3 to guarantee it falls within the 225 bp Read 2 sequencing window.\n\n\n**Considering Constant Region Probes**\n\nI'm now re-evaluating the role of bead modifications in TCR capture. Thinking about how the constant regions can act as anchor points for the oligo binding, allowing for better coverage. The key is in using probes that are complementary to the constant regions to increase the probability of capturing the CDR3 region within the Read 2 window.\n\n\n**Prioritizing Oligo Design**\n\nI'm now prioritizing the design of the TCR-specific capture oligos, and how those modifications would be applied to the beads. My primary focus is on how to best position these oligos relative to the CDR3 region. I want to ensure that the CDR3 is within the read length, while also considering how the reverse transcription would work on the beads.\n\n\n**Reflecting on TCR Sequencing**\n\nI'm now contemplating that modifying the existing bead design is the most probable path forward. The idea of using TCR-specific capture oligos on the beads, specifically targeting flanking sequences near the CDR3 region, seems like the most effective solution for ensuring targeted CDR3 capture during sequencing.\n\n\n**Considering CDR3 Coverage**\n\nI'm now contemplating how to improve the strategy for capturing and sequencing the TCR CDR3 region using the existing system and constraints. My current thinking is that to overcome the short read length, I need to design TCR-specific capture oligos that bind downstream of the CDR3, which should pull the region closer to the capture point.\n\n\n**Analyzing Capture Options**\n\nI am now focusing on the best way to get the CDR3 region into the read. Considering a 3' capture, I'm thinking specific capture oligos, potentially targeting the constant regions, are key. I'll need to see if the oligo design and read length will accommodate the CDR3.\n\n\n**Evaluating Targeted Priming**\n\nI'm now contemplating that modifying the beads is the preferred approach, especially in light of Rhapsody's TCR/BCR kits. Adding capture oligos targeting constant regions downstream of the CDR3, for reverse transcription, could bring the CDR3 within the read length during the initial capture and library preparation.\n\n\n**Considering Priming Locations**\n\nI'm now contemplating that modifying the beads is the most effective approach. The key lies in strategic capture, with particular emphasis on where the oligos should bind. The aim is to ensure that reverse transcription primes near the CDR3, bringing the region into the read. The potential modification would bring the constant regions closer.\n\n\n**Considering the Problem Statement**\n\nI'm now contemplating that modifying the beads is the most effective approach. The key lies in strategic positioning of capture oligos, perhaps designed to target regions downstream of the CDR3, to ensure the CDR3 lies within the sequencing read, and how this will be incorporated into the Rhapsody workflow.\n\n\n**Considering Rhapsody Bead Design**\n\nI'm now contemplating that modifying the beads is the preferred approach. The most effective strategy involves adding capture oligos to the bead. These should be designed to target the constant regions, downstream from the CDR3. This helps place the CDR3 region into the read.\n\n\n**Reflecting on TCR Capture**\n\nI'm now thinking about how to adapt the Rhapsody workflow to better capture the TCR CDR3 region. The key lies in modifying the beads. I'm considering adding TCR-specific oligos or replacing the poly(dT) tail, potentially targeting regions downstream of the CDR3, to ensure the region is sequenced.\n\n\n**Evaluating Oligo Incorporation**\n\nI'm now contemplating that modifying the beads to incorporate TCR-specific capture oligos is key. Considering how to best position these on the beads relative to the CDR3 region. The goal is the inclusion of the CDR3 within the read length during the reverse transcription process.\n\n\n**Considering Solution Approaches**\n\nI'm now contemplating that modifying the beads is the most effective way to address the issue. Adding TCR-specific capture oligos, perhaps targeting the constant regions, would facilitate the positioning of the CDR3 region for subsequent sequencing, though this presents a challenge to the existing workflow.\n\n\n**Considering Bead Modification Choices**\n\nI'm now contemplating that modifying the beads to improve TCR capture is the best option. I'm focusing on incorporating oligos that can target regions downstream from the CDR3. This approach aims to bring the CDR3 within the sequencing read length.\n\n**Considering Library Prep Strategies**\n\nI'm now contemplating that modifying the beads to improve the TCR capture will be necessary. My focus is on adding a strategy using oligos that target regions downstream from the CDR3, and how that will fit into the existing workflow.\n\n\n**Considering PCR Amplification After Capture**\n\nI'm now thinking about leveraging PCR amplification post-capture. The core of my current line of thinking revolves around designing primers to amplify the CDR3 region specifically after the initial capture phase. This may be a strong method of ensuring the inclusion of the CDR3 during sequencing.\n\n\n**Reflecting on TCR Sequencing**\n\nI'm now contemplating that modifying the existing bead design is the most probable path forward. The idea of using TCR-specific capture oligos on the beads, specifically targeting flanking sequences near the CDR3 region, seems like the most effective solution for ensuring targeted CDR3 capture during sequencing.\n\n\n**Reflecting on TCR Sequencing**\n\nI'm now contemplating that modifying the existing bead design is the most probable path forward. The idea of using TCR-specific capture oligos on the beads, specifically targeting flanking sequences near the CDR3 region, seems like the most effective solution for ensuring targeted CDR3 capture during sequencing.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762216769,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 6439,
        "prompt_tokens": 422,
        "total_tokens": 6861,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 6368,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.016061859,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001266,
          "upstream_inference_completions_cost": 0.0160975
        }
      },
      "provider": "Google"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "A PhD student used BD Rhapsody system to achieve single cell barcoding in a high throughput manner. Single cell barcoding was achieved using magnetic beads that were linked with a DNA oligo containing a universal oligo, cell label, UMI and a PolydT tail. This schematic worked well to generate sequencing libraries for Abseq, Sample Tag, and targeted mRNA panels. Subsequent next generation sequencing using 75 by 225 configuration on Illumina sequencer also worked well. Recently, the PhD student wanted to add single cell TCR transcript capture and sequencing. He tried to use the same bead schematic and sequencing modality for TCR transcript capturing and sequencing, but he was not able to obtain the CDR3 region sequences on the TCR. He would like to keep the sequencing modality as 75 by 225 since this was the cheapest option. Moreover, he would like to keep using the BD Rhapsody system to achieve single cell capturing and labeling in a high throughout manner. What could he do to appropriately obtain the CDR3 region sequences?\n\n\nAnswer Choices:\nA. First Step: Use the existing poly(dT) tail to capture the mRNA as usual. Second Step: Add TCR-specific capture oligos to the beads. These oligos should hybridize to sequences upstream of the V(D)J junctions, which include the CDR3 region. This will ensure specific capture of the TCR transcripts.\nB. Add template switch oligos (TSO) after UMI on the DNA oligo on the beads. After reverse transcription, add TSO to 3\u2019 end during PCR reaction to achieve template switching.\nC. Modify the beads to include capture oligos specific to the TCR regions, particularly focusing on the conserved regions flanking the CDR3. These capture oligos should be designed to bind upstream and downstream of the CDR3 region to ensure it is included in the captured sequence.\nD. After capturing the TCR transcripts, design primers that bind to the regions flanking the CDR3 region for subsequent PCR amplification.\nE. Use a different sequencing modality such as 2 by 150."
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762216769-mepX5PYbxF1DumMy5RNB",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"The most appropriate solution is to modify the capture strategy on the beads to specifically target TCR transcripts and ensure the CDR3 region is included. When using an existing poly-dT tail as the sole capture mechanism for mRNA, the sequencing (even with 225 bp read length) might not extend far enough from the 3' poly-A tail to consistently cover the entire V(D)J region, which includes the CDR3. TCR sequencing requires a targeted approach.\",\n  \"answer_letter\": \"C\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Examining the Problem**\n\nI'm focused on the PhD student's roadblock: getting those crucial CDR3 sequences. It's frustrating when the rest of the experiment \u2013 Abseq and sample tagging \u2013 works perfectly, yet this key piece is missing. I'm considering potential bottlenecks in the data analysis pipeline, like alignment parameters or reference databases.\n\n\n**Reassessing Capture Strategies**\n\nI'm now zeroing in on the poly-dT priming. The current setup, while good for general mRNA panels, might be the Achilles heel. The CDR3 region's variable positioning relative to the poly-A tail is a critical factor. I'm leaning toward needing a secondary capture method targeting upstream regions. The challenge is integrating this without disrupting the existing Rhapsody workflow and sequencing constraints.\n\n\n**Refining Capture Methods**\n\nI am now focusing on solution A: the two-step capture strategy, utilizing both poly-dT priming and TCR-specific oligos. The crucial point is the design and placement of these TCR oligos. I need to identify conserved regions upstream of the V(D)J junctions to ensure efficient capture across various TCR transcripts. The challenge is ensuring these new oligos are compatible with the Rhapsody workflow and do not affect the existing bead structure or affect other mRNA panels.\n\n\n**Contemplating the Bead Design**\n\nI'm now zeroing in on a modified version of Option A. While the two-step approach seems promising, I'm questioning the *addition* of TCR-specific capture oligos. Instead, I'm leaning toward integrating these oligos directly into the bead's design. This would simplify the workflow and ensure these specific oligos are present during the initial mRNA capture. I need to make sure the oligo design allows for enough space for the UMI, cell label, and capture site.\n\n\n**Comparing the Solutions**\n\nI am now carefully weighing the proposed solutions. Option A, the two-step strategy, feels somewhat cumbersome. Option B seems less relevant, focusing more on cDNA synthesis than targeted capture of the CDR3. However, I am leaning toward a modified version of Option C: adapting the bead design with TCR-specific capture oligos. This is the most direct approach, addressing the core issue. I'm prioritizing the design and placement of these oligos to flank the CDR3, and assessing the constraints of the Rhapsody system.\n\n\n**Considering Design Implications**\n\nI'm now fully immersed in the bead design. My primary focus is on Option C: integrating TCR-specific capture oligos. I'm carefully analyzing the oligo design, especially the placement of these capture probes. The key is to ensure they bind efficiently to the flanking conserved regions, maximizing the probability of CDR3 capture. The design considerations include the oligo's Tm, its potential for self-dimerization, and its compatibility within the existing Rhapsody workflow and sequencing constraints.\n\n\n**Evaluating Capture Efficiency**\n\nI'm now comparing and contrasting the solutions, specifically Option A and C. Option A's two-step approach is less desirable. Option C, modifying the beads with TCR-specific capture probes, seems the most efficient. I'm prioritizing the flanking region design to ensure high-efficiency capture regardless of CDR3 placement. Furthermore, I am assessing the constraints, focusing on compatibility within the Rhapsody system.\n\n\n**Reflecting on the Approach**\n\nI am now focusing on the optimal approach: modifying the beads with TCR-specific capture probes (Option C). Unlike a two-step capture, this is simpler. My next step will be to refine the probe design. The key is to target conserved regions on the 3' side of the CDR3, followed by reverse transcription. This is vital to include the crucial V(D)J region.\n\n\n**Reflecting on the Options**\n\nI'm now consolidating the best path forward. A modification to the beads (Option C) makes the most sense. Although, I need to focus on a design that uses oligos specific for TCR regions to capture the mRNAs. This is the optimal solution for CDR3 region capture regardless of its placement, and fits within the parameters set.\n\n\n**Evaluating Targeted Priming**\n\nI'm now zeroing in on the crux of the matter: targeted capture. Poly-dT priming is failing. Therefore, I need to design bead-bound oligos that specifically target the conserved regions near the CDR3. This is the surest approach, while remaining within the system parameters.\n\n\n**Reassessing Bead Modifications**\n\nI'm now zeroing in on Option C, bead modifications. The core idea is clear: replace or supplement the poly-dT with TCR-specific capture probes. I'm focusing on the *design* of these probes. My key goal is that they'll be able to grab onto conserved regions downstream of the CDR3, and prime reverse transcription to then include the critical V(D)J region.\n\n\n**Analyzing Capture Specificity**\n\nI'm now back to the core challenge: achieving reliable CDR3 capture. The poly-dT priming clearly isn't cutting it. To solve the problem, I'll need to design new oligo probes. I plan on placing these oligos on the bead, and specifically targeting conserved regions downstream of the CDR3. This is the optimal approach.\n\n\n**Revising Primer Specificity**\n\nI'm now zeroing in on the crucial oligo placement, and where to perform reverse transcription. It's clear that poly-dT capture is the roadblock, the issue being that it bypasses the critical V(D)J region. The solution must target specific regions that flank the CDR3, and prime reverse transcription from the 3' end, towards the 5' end.\n\n\n**Evaluating Reverse Transcription Primer**\n\nI'm now prioritizing bead modification. The aim is to include a primer that binds a conserved region 3' of the CDR3. This primer must be compatible with the Rhapsody workflow. I need to ensure it primes reverse transcription efficiently to capture the entire V(D)J region, and design it to allow for the UMI and cell label.\n\n\n**Revising Primer Specificity**\n\nIt's clear, a targeted approach is the most efficient and correct solution. While Option C, modifying the bead design, is promising, I need to focus on designing the oligo so it's complementary to the TCR constant region. This would ensure efficient capture of the V(D)J region.\n\n\n**Evaluating Prime Placement**\n\nI'm now zeroing in on the strategy for including the CDR3 region. I have to design a targeted approach using specific oligos for the TCR, and the most efficient seems to be the one that captures the end region of the mRNA. The design will be crucial to include the CDR3.\n\n\n**Reflecting on TCR Capture**\n\nI'm now zeroing in on the fundamental issue: poly-dT capture is failing to consistently grab the CDR3 region. The solution must involve a targeted approach. Bead modification with oligos specific to conserved TCR regions, particularly the constant region, is the best path. This design will directly ensure efficient capture.\n\n\n**Reflecting on TCR Capture**\n\nIt's clear, a targeted approach is the most efficient and correct solution. The best plan is to adapt the bead oligo with primers that match the constant region of the TCR transcript. This strategy ensures the CDR3 is captured and sequenced.\n\n\n**Reiterating the Core Challenge**\n\nI'm now focused on the bead design, and in particular on the need for TCR-specific capture. The goal is clear: to efficiently capture the V(D)J region, and ensure that the crucial CDR3 is included in the sequenced cDNA, irrespective of its position.\n\n\n**Reiterating the Core Challenge**\n\nThe crux is still capturing that crucial CDR3 region, and I must design a targeted method. The existing poly-dT priming isn't cutting it. My focus, therefore, must now center on modifying the bead's oligo with specific primers. I'm focusing on the constant region of the TCR transcripts.\n\n\n**Reiterating the Core Challenge**\n\nI'm now focused on the challenge: the poly-dT approach is failing to consistently sequence the V(D)J region, and capture the CDR3. Therefore I must prioritize modifying the beads. I want to replace the current oligo, and focus on using TCR-specific capture for robust and consistent sequencing.\n\n\n**Reflecting on TCR Capture**\n\nIt's clear, a targeted approach is the most efficient and correct solution. The poly-dT capture is not consistently capturing the CDR3. Therefore I must modify the bead oligo. I need to design primers specific to the TCR constant region.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Examining the Problem**\n\nI'm focused on the PhD student's roadblock: getting those crucial CDR3 sequences. It's frustrating when the rest of the experiment \u2013 Abseq and sample tagging \u2013 works perfectly, yet this key piece is missing. I'm considering potential bottlenecks in the data analysis pipeline, like alignment parameters or reference databases.\n\n\n**Reassessing Capture Strategies**\n\nI'm now zeroing in on the poly-dT priming. The current setup, while good for general mRNA panels, might be the Achilles heel. The CDR3 region's variable positioning relative to the poly-A tail is a critical factor. I'm leaning toward needing a secondary capture method targeting upstream regions. The challenge is integrating this without disrupting the existing Rhapsody workflow and sequencing constraints.\n\n\n**Refining Capture Methods**\n\nI am now focusing on solution A: the two-step capture strategy, utilizing both poly-dT priming and TCR-specific oligos. The crucial point is the design and placement of these TCR oligos. I need to identify conserved regions upstream of the V(D)J junctions to ensure efficient capture across various TCR transcripts. The challenge is ensuring these new oligos are compatible with the Rhapsody workflow and do not affect the existing bead structure or affect other mRNA panels.\n\n\n**Contemplating the Bead Design**\n\nI'm now zeroing in on a modified version of Option A. While the two-step approach seems promising, I'm questioning the *addition* of TCR-specific capture oligos. Instead, I'm leaning toward integrating these oligos directly into the bead's design. This would simplify the workflow and ensure these specific oligos are present during the initial mRNA capture. I need to make sure the oligo design allows for enough space for the UMI, cell label, and capture site.\n\n\n**Comparing the Solutions**\n\nI am now carefully weighing the proposed solutions. Option A, the two-step strategy, feels somewhat cumbersome. Option B seems less relevant, focusing more on cDNA synthesis than targeted capture of the CDR3. However, I am leaning toward a modified version of Option C: adapting the bead design with TCR-specific capture oligos. This is the most direct approach, addressing the core issue. I'm prioritizing the design and placement of these oligos to flank the CDR3, and assessing the constraints of the Rhapsody system.\n\n\n**Considering Design Implications**\n\nI'm now fully immersed in the bead design. My primary focus is on Option C: integrating TCR-specific capture oligos. I'm carefully analyzing the oligo design, especially the placement of these capture probes. The key is to ensure they bind efficiently to the flanking conserved regions, maximizing the probability of CDR3 capture. The design considerations include the oligo's Tm, its potential for self-dimerization, and its compatibility within the existing Rhapsody workflow and sequencing constraints.\n\n\n**Evaluating Capture Efficiency**\n\nI'm now comparing and contrasting the solutions, specifically Option A and C. Option A's two-step approach is less desirable. Option C, modifying the beads with TCR-specific capture probes, seems the most efficient. I'm prioritizing the flanking region design to ensure high-efficiency capture regardless of CDR3 placement. Furthermore, I am assessing the constraints, focusing on compatibility within the Rhapsody system.\n\n\n**Reflecting on the Approach**\n\nI am now focusing on the optimal approach: modifying the beads with TCR-specific capture probes (Option C). Unlike a two-step capture, this is simpler. My next step will be to refine the probe design. The key is to target conserved regions on the 3' side of the CDR3, followed by reverse transcription. This is vital to include the crucial V(D)J region.\n\n\n**Reflecting on the Options**\n\nI'm now consolidating the best path forward. A modification to the beads (Option C) makes the most sense. Although, I need to focus on a design that uses oligos specific for TCR regions to capture the mRNAs. This is the optimal solution for CDR3 region capture regardless of its placement, and fits within the parameters set.\n\n\n**Evaluating Targeted Priming**\n\nI'm now zeroing in on the crux of the matter: targeted capture. Poly-dT priming is failing. Therefore, I need to design bead-bound oligos that specifically target the conserved regions near the CDR3. This is the surest approach, while remaining within the system parameters.\n\n\n**Reassessing Bead Modifications**\n\nI'm now zeroing in on Option C, bead modifications. The core idea is clear: replace or supplement the poly-dT with TCR-specific capture probes. I'm focusing on the *design* of these probes. My key goal is that they'll be able to grab onto conserved regions downstream of the CDR3, and prime reverse transcription to then include the critical V(D)J region.\n\n\n**Analyzing Capture Specificity**\n\nI'm now back to the core challenge: achieving reliable CDR3 capture. The poly-dT priming clearly isn't cutting it. To solve the problem, I'll need to design new oligo probes. I plan on placing these oligos on the bead, and specifically targeting conserved regions downstream of the CDR3. This is the optimal approach.\n\n\n**Revising Primer Specificity**\n\nI'm now zeroing in on the crucial oligo placement, and where to perform reverse transcription. It's clear that poly-dT capture is the roadblock, the issue being that it bypasses the critical V(D)J region. The solution must target specific regions that flank the CDR3, and prime reverse transcription from the 3' end, towards the 5' end.\n\n\n**Evaluating Reverse Transcription Primer**\n\nI'm now prioritizing bead modification. The aim is to include a primer that binds a conserved region 3' of the CDR3. This primer must be compatible with the Rhapsody workflow. I need to ensure it primes reverse transcription efficiently to capture the entire V(D)J region, and design it to allow for the UMI and cell label.\n\n\n**Revising Primer Specificity**\n\nIt's clear, a targeted approach is the most efficient and correct solution. While Option C, modifying the bead design, is promising, I need to focus on designing the oligo so it's complementary to the TCR constant region. This would ensure efficient capture of the V(D)J region.\n\n\n**Evaluating Prime Placement**\n\nI'm now zeroing in on the strategy for including the CDR3 region. I have to design a targeted approach using specific oligos for the TCR, and the most efficient seems to be the one that captures the end region of the mRNA. The design will be crucial to include the CDR3.\n\n\n**Reflecting on TCR Capture**\n\nI'm now zeroing in on the fundamental issue: poly-dT capture is failing to consistently grab the CDR3 region. The solution must involve a targeted approach. Bead modification with oligos specific to conserved TCR regions, particularly the constant region, is the best path. This design will directly ensure efficient capture.\n\n\n**Reflecting on TCR Capture**\n\nIt's clear, a targeted approach is the most efficient and correct solution. The best plan is to adapt the bead oligo with primers that match the constant region of the TCR transcript. This strategy ensures the CDR3 is captured and sequenced.\n\n\n**Reiterating the Core Challenge**\n\nI'm now focused on the bead design, and in particular on the need for TCR-specific capture. The goal is clear: to efficiently capture the V(D)J region, and ensure that the crucial CDR3 is included in the sequenced cDNA, irrespective of its position.\n\n\n**Reiterating the Core Challenge**\n\nThe crux is still capturing that crucial CDR3 region, and I must design a targeted method. The existing poly-dT priming isn't cutting it. My focus, therefore, must now center on modifying the bead's oligo with specific primers. I'm focusing on the constant region of the TCR transcripts.\n\n\n**Reiterating the Core Challenge**\n\nI'm now focused on the challenge: the poly-dT approach is failing to consistently sequence the V(D)J region, and capture the CDR3. Therefore I must prioritize modifying the beads. I want to replace the current oligo, and focus on using TCR-specific capture for robust and consistent sequencing.\n\n\n**Reflecting on TCR Capture**\n\nIt's clear, a targeted approach is the most efficient and correct solution. The poly-dT capture is not consistently capturing the CDR3. Therefore I must modify the bead oligo. I need to design primers specific to the TCR constant region.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762216769,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 5743,
        "prompt_tokens": 422,
        "total_tokens": 6165,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 5629,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.014339259,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001266,
          "upstream_inference_completions_cost": 0.0143575
        }
      },
      "provider": "Google"
    }
  }
]